Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Aggregation of Therapeutic Proteins (eBook)

eBook Download: EPUB
2010
John Wiley & Sons (Verlag)
978-1-118-04358-5 (ISBN)

Lese- und Medienproben

Aggregation of Therapeutic Proteins -
Systemvoraussetzungen
134,99 inkl. MwSt
(CHF 129,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.

WEI WANG, PhD, is a Research Fellow at Pfizer Global Biologics. He is also Adjunct Professor in the School of Pharmacy and Health at the University of the Pacific in California and Guest Professor at Shandong University in China.

CHRISTOPHER J. ROBERTS, PhD, is Associate Professor of Chemical Engineering at the University of Delaware. Previously, he was a senior research scientist in pharmaceutical R & D at Pfizer.


This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.

WEI WANG, PhD, is a Research Fellow at Pfizer Global Biologics. He is also Adjunct Professor in the School of Pharmacy and Health at the University of the Pacific in California and Guest Professor at Shandong University in China. CHRISTOPHER J. ROBERTS, PhD, is Associate Professor of Chemical Engineering at the University of Delaware. Previously, he was a senior research scientist in pharmaceutical R & D at Pfizer.

"Among their topics are fundamental structures and behaviors of
proteins; protein aggregation pathways, kinetics, and
thermodynamics; the identification and impact of aggregate-prone
regions in proteins and therapeutic monoclonal antibodies; external
factors affecting protein aggregation; experimental detection and
characterization of protein aggregates; approaches to controlling
it during bulk production; effects of formulation interfaces, and
drug product manufacturing operations on aggregation and particle
formation; approaches to managing it in product development;
aggregation and immunogenicity of therapeutic proteins; and a
regulatory perspective on aggregates as a product quality
attribute." (SciTech Book News, December 2010)

Erscheint lt. Verlag 28.12.2010
Sprache englisch
Themenwelt Medizin / Pharmazie
Naturwissenschaften Biologie
Naturwissenschaften Chemie
Schlagworte Biowissenschaften • Chemie • Chemistry • Drug Discovery & Development • Life Sciences • protein aggregation, therapeutic proteins, aggregation of therapeutic proteins, consequences of protein aggregation, therapeutic proteins development • Proteine • Proteine u. Makromoleküle • Proteine u. Makromoleküle • Proteins & Macromolecules • Protein Science • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung
ISBN-10 1-118-04358-8 / 1118043588
ISBN-13 978-1-118-04358-5 / 9781118043585
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Entwicklung und Gestaltung von Fließgewässern

von Heinz Patt

eBook Download (2024)
Springer Fachmedien Wiesbaden (Verlag)
CHF 87,90